FTO gene variants are associated with the increased risk of polycystic ovary syndrome: a meta-analysis
摘要
Polycystic ovary syndrome (PCOS) is a complex endocrine disorder caused by the interplay of both genetic and lifestyle factors. Several case-control studies have investigated the link between variants of the fat mass and obesity associated (FTO) gene and PCOS; however, the findings are not conclusive.
ObjectiveThe primary objective of this meta-analysis was to investigate the association between FTO gene variants and susceptibility to PCOS.
MethodsA thorough literature review was carried out in ScienceDirect, PubMed, and Google Scholar for research published by September 30, 2025. Ultimately, a total of 23 eligible studies, comprising 20 with Asian participants, five with Caucasian participants, two with African participants, and one with mixed ethnicities, were included to extract genotype data related to PCOS and FTO gene variants, rs1421085, rs8050136 and rs9939609. The association strength was evaluated by calculating Odds ratios (ORs) along with their respective 95% confidence intervals (CIs).
ResultsThe pooled data revealed statistically significant evidence supporting a modestly elevated susceptibility to PCOS for rs9939609 (AA vs. AT + TT: OR = 1.56; 95% CI = 1.17–2.07; p = 0.002), rs8050136 (AA vs. CA + CC: OR = 1.36, 95% CI = 1.11–1.68, p = 0.004) and rs1421085 (CC vs. CT + TT: OR = 1.26, 95% CI = 1.01–1.56, p = 0.036) variants in overall population. No publication bias was detected for these three genetic variants.
ConclusionThe FTO variants are linked to an increased risk of PCOS. As FTO single nucleotide polymorphisms (SNPs) are influenced epigenetically by multiple mechanisms impacting metabolism, further research should consider incorporating genotype as a crucial element in the epigenetic analysis of the relationship between FTO genetic variants and PCOS susceptibility.